by Nicole Overmars | Mar 24, 2022 | Press Releases
2N Pharma has big ambitions. Our mission is to do what no one has yet managed: develop effective drugs with our innovative approach for the neurological diseases ALS and Parkinson’s. Unmet medical need Parkinson’s disease was first described...
by Nicole Overmars | Feb 11, 2022 | Press Releases
On the occasion of today’s International Day of Women and Girls in Science, we spoke with Angelique Corthals, an inspiring woman in STEM. She is a multifaceted scientist, and has years of experience in the fields of metabolic dysfunction and neurological...
by Nicole Overmars | Jan 19, 2022 | Press Releases
AALBORG, Denmark – We are thrilled to announce that 2N Pharma will be a showcase presenter at BioSeed 2022. 2N Pharma will attend BioSeed, OBN’s Early-Stage Life Science Investment Event. The event takes place in London on January 25. Chair Alex Leech, CEO Preben...
by Nicole Overmars | Jan 5, 2022 | Press Releases
AALBORG, Denmark – CEO and Co-Founder Preben Bruun-Nyzell from 2N Pharma will participate in BIO Partnering during the 40th Annual J.P. Morgan Healthcare Conference, held virtually, from January 10-14. About 2N Pharma2N Pharma is a small biotech...
by Nicole Overmars | Dec 23, 2021 | Press Releases
2N Pharma wishes you and your loved ones Season’s Greetings and a prosperous New Year. As the New Year is drawing near, we want to use the opportunity to highlight some of the events of last year in video form. For instance, our board of directors and team...
by Nicole Overmars | Dec 12, 2021 | Press Releases
ALS/MND researchers from around the world convened virtually from December 7-10. The aim is to share knowledge and learn about the most recent advances in the field at the 32nd International Symposium on ALS/MND. John, Anne, and Lisa also attended the...
Recent Comments